TAZCOV Syrup Remedy for Acute respiratory infections (ARIs) including COVID-19

TAZCOV represents a significant milestone in Uganda's pharmaceutical research, demonstrating the potential of indigenous medicinal plants in developing evidence-based natural remedies. The product has received regulatory approval from the National Drug Authority and is supported by the Government of Uganda through the Secretariat of Science, Technology and Innovation. This innovation showcases Busitema University's commitment to translating research into practical health solutions for Ugandan communities.

Problem Statement

Acute respiratory infections (ARIs) including COVID-19, common cold, influenza, pneumonia, and bronchiolitis remain a significant health burden in Uganda and globally, with limited effective natural treatment options available.

Project Status
Commercialized / Market-Ready
Description

TAZCOV is a natural remedy formulated from Ugandan medicinal plants for symptomatic management of acute respiratory infections (ARIs) like COVID-19, common Cold, influenza (flu), sore throat, Parainfluenza, Respiratory syncytial virus infection, rhinitis, pharyngitis, bronchitis, pneumonia and bronchiolitis. It has scientifically proven antiviral, anti-inflammatory, antioxidant, and immunomodulation properties. These pharmacological activities are due to abundant skimmianine, berberine, apigenin, luteolin, quercetin, ascorbic acid and betulinic acid. TAZCOV successfully underwent a rigorous scientific process of preclinical evaluation and was notified by the National Drug Authority (THA1087) and was supported by the Government of Uganda through the Secretariat of Science, Technology and Innovation.

Innovation / Solution

A natural, scientifically-formulated remedy derived from locally available Ugandan medicinal plants that provides symptomatic relief for acute respiratory infections, offering an alternative to synthetic drugs with proven antiviral, anti-inflammatory, and immunomodulatory properties.

Key Features

• Scientifically proven antiviral properties
• Anti-inflammatory activity
• Antioxidant properties
• Immunomodulation effects
• Contains bioactive compounds: skimmianine, berberine, apigenin, luteolin, quercetin, ascorbic acid, betulinic acid
• Natural remedy from Ugandan medicinal plants
• Notified by National Drug Authority (THA1087)

Associated Programme
PhD in Chemistry; PhD in Natural Resource and Environmental Sciences
Location / Campus
Natural Products Research and Innovation Centre, Busitema University
Team Leader Name
Dr. Samuel Baker Obakiro
Team Leader Photo
Dr. Samuel Baker Obakiro
Target Beneficiaries

Patients with acute respiratory infections including COVID-19, common cold, influenza, sore throat, parainfluenza, RSV, rhinitis, pharyngitis, bronchitis, pneumonia, and bronchiolitis; Healthcare providers; Ugandan communities

Project Image
TAZCOV Syrup